{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T04:42:53Z","timestamp":1792644173646,"version":"4.5.0"},"reference-count":56,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,7]],"date-time":"2022-12-07T00:00:00Z","timestamp":1670371200000},"content-version":"am","delay-in-days":371,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.autrev.2021.102987","type":"journal-article","created":{"date-parts":[[2021,10,28]],"date-time":"2021-10-28T13:43:56Z","timestamp":1635428636000},"page":"102987","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"title":["Cancer incidence in primary Sj\u00f6gren's syndrome: Data from the French hospitalization database"],"prefix":"10.1016","volume":"20","author":[{"given":"Radjiv","family":"Goulabchand","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Malafaye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Jacot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philine","family":"Witkowski Durand Viel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques","family":"Morel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9dric","family":"Lukas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pauline","family":"Rozier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvain","family":"Lamure","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dani\u00e8le","family":"Noel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Molinari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thibault","family":"Mura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Guilpain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.autrev.2021.102987_bb0005","doi-asserted-by":"crossref","first-page":"102690","DOI":"10.1016\/j.autrev.2020.102690","article-title":"Minor salivary gland biopsy: its role in the classification and prognosis of Sj\u00f6gren\u2019s syndrome","volume":"19","author":"Bautista-Vargas","year":"2020","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2021.102987_bb0010","doi-asserted-by":"crossref","DOI":"10.3390\/jcm9072299","article-title":"Current state of knowledge on primary Sj\u00f6gren\u2019s syndrome, an autoimmune Exocrinopathy","volume":"9","author":"Parisis","year":"2020","journal-title":"J Clin Med"},{"key":"10.1016\/j.autrev.2021.102987_bb0015","first-page":"247","article-title":"The epidemiology of Sj\u00f6gren\u2019s syndrome","volume":"6","author":"Patel","year":"2014","journal-title":"Clin Epidemiol"},{"key":"10.1016\/j.autrev.2021.102987_bb0020","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1177\/0961203319889666","article-title":"Characteristics of Chinese patients with primary Sj\u00f6gren\u2019s syndrome: preliminary report of a multi-centre registration study","volume":"29","author":"Xu","year":"2020","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2021.102987_bb0025","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1002\/art.10221","article-title":"Long-term risk of mortality and lymphoproliferative disease and predictive classification of primary Sj\u00f6gren\u2019s syndrome","volume":"46","author":"Ioannidis","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2021.102987_bb0030","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1136\/annrheumdis-2014-206418","article-title":"Systemic activity and mortality in primary Sj\u00f6gren syndrome: predicting survival using the EULAR-SS disease activity index (ESSDAI) in 1045 patients","volume":"75","author":"Brito-Zer\u00f3n","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2021.102987_bb0035","first-page":"1","article-title":"Population-based study of patients with primary Sj\u00f6gren\u2019s syndrome and lymphoma: lymphoma subtypes, clinical characteristics, and gender differences","author":"Vasaitis","year":"2020","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.autrev.2021.102987_bb0040","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1007\/s00296-019-04433-2","article-title":"Incidence of cancer in a cohort of patients with primary Sj\u00f6gren syndrome in Argentina","volume":"39","author":"Brom","year":"2019","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.autrev.2021.102987_bb0045","doi-asserted-by":"crossref","DOI":"10.3899\/jrheum.191027","article-title":"Bidirectional relationship between primary Sj\u00f6gren\u2019s syndrome and non- Hodgkin\u2019s lymphoma: a Nationwide population-based study","author":"Wang","year":"2020","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2021.102987_bb0050","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1136\/ard.2005.041186","article-title":"Lymphoma and other malignancies in primary Sj\u00f6gren\u2019s syndrome: a cohort study on cancer incidence and lymphoma predictors","volume":"65","author":"Theander","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2021.102987_bb0055","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1136\/annrheumdis-2011-200402","article-title":"Incidence of cancer in a nationwide population cohort of 7852 patients with primary Sjogren\u2019s syndrome in Taiwan","volume":"71","author":"Weng","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2021.102987_bb0060","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1136\/annrheumdis-2013-203305","article-title":"Primary Sjogren\u2019s syndrome and malignancy risk: a systematic review and meta-analysis","volume":"73","author":"Liang","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2021.102987_bb0065","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s13045-017-0464-5","article-title":"Characterization and risk estimate of cancer in patients with primary Sj\u00f6gren syndrome","volume":"10","author":"Brito-Zer\u00f3n","year":"2017","journal-title":"J Hematol Oncol"},{"key":"10.1016\/j.autrev.2021.102987_bb0070","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0089513","article-title":"Association between socioeconomic factors and cancer risk: a population cohort study in Scotland (1991-2006)","volume":"9","author":"Sharpe","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.autrev.2021.102987_bb0075","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1080\/0284186X.2020.1817548","article-title":"Education, income and risk of cancer: results from a Norwegian registry-based study","volume":"59","author":"Larsen","year":"2020","journal-title":"Acta Oncol"},{"key":"10.1016\/j.autrev.2021.102987_bb0080","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1161\/CIRCULATIONAHA.115.017719","article-title":"Introduction to the analysis of survival data in the presence of competing risks","volume":"133","author":"Austin","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.autrev.2021.102987_bb0085","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1177\/0961203318801673","article-title":"Primary Sj\u00f6gren\u2019s syndrome","volume":"27","author":"Bowman","year":"2018","journal-title":"Lupus"},{"issue":"Suppl 126","key":"10.1016\/j.autrev.2021.102987_bb0090","first-page":"40","article-title":"Risk of non-Hodgkin\u2019s lymphoma and thyroid cancer in primary Sj\u00f6gren\u2019s syndrome measured using the Korean Health Insurance Claims Database","volume":"38","author":"Ahn","year":"2020","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.autrev.2021.102987_bb0095","doi-asserted-by":"crossref","DOI":"10.3390\/jcm9123794","article-title":"Pathogenetic mechanisms implicated in Sj\u00f6gren\u2019s syndrome lymphomagenesis: a review of the literature","volume":"9","author":"Stergiou","year":"2020","journal-title":"J Clin Med"},{"key":"10.1016\/j.autrev.2021.102987_bb0100","article-title":"Lymphomas complicating primary Sj\u00f6gren\u2019s syndrome: from autoimmunity to lymphoma","author":"Nocturne","year":"2019","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2021.102987_bb0105","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/nrrheum.2018.1","article-title":"B cells in the pathogenesis of primary Sj\u00f6gren syndrome","volume":"14","author":"Nocturne","year":"2018","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.autrev.2021.102987_bb0110","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.autrev.2018.08.007","article-title":"Lymphomagenesis in Sj\u00f6gren\u2019s syndrome: predictive biomarkers towards precision medicine","volume":"18","author":"Goules","year":"2019","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2021.102987_bb0115","doi-asserted-by":"crossref","first-page":"102316","DOI":"10.1016\/j.jaut.2019.102316","article-title":"Predictive markers of lymphomagenesis in Sj\u00f6gren\u2019s syndrome: from clinical data to molecular stratification","volume":"104","author":"Kapsogeorgou","year":"2019","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2021.102987_bb0120","doi-asserted-by":"crossref","first-page":"102648","DOI":"10.1016\/j.jaut.2021.102648","article-title":"A biomarker for lymphoma development in Sjogren\u2019s syndrome: salivary gland focus score","volume":"121","author":"Chatzis","year":"2021","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2021.102987_bb0125","doi-asserted-by":"crossref","first-page":"8629","DOI":"10.1007\/s11033-012-1717-6","article-title":"C-X-C chemokine receptor type 5 gene polymorphisms are associated with non-Hodgkin lymphoma","volume":"39","author":"Song","year":"2012","journal-title":"Mol Biol Rep"},{"key":"10.1016\/j.autrev.2021.102987_bb0130","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s00296-020-04524-5","article-title":"Serum CXCL13 levels are associated with lymphoma risk and lymphoma occurrence in primary Sj\u00f6gren\u2019s syndrome","volume":"40","author":"Traianos","year":"2020","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.autrev.2021.102987_bb0135","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.21037\/jtd.2019.02.90","article-title":"Thymic epithelial tumor complicated by immunological abnormalities: results from a single-center retrospective study in China","volume":"11","author":"Shi","year":"2019","journal-title":"J Thorac Dis"},{"key":"10.1016\/j.autrev.2021.102987_bb0140","first-page":"54","article-title":"Primary thymic mucosa-associated lymphoid tissue lymphoma: 7 clinical cases report and a review of the literature","volume":"41","author":"Xu","year":"2020","journal-title":"Zhonghua Xue Ye Xue Za Zhi"},{"key":"10.1016\/j.autrev.2021.102987_bb0145","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/s40792-019-0696-4","article-title":"Primary thymic MALT lymphoma in a patient with Sj\u00f6gren\u2019s syndrome and multiple lung cysts: a case report","volume":"5","author":"Hirokawa","year":"2019","journal-title":"Surg Case Rep"},{"key":"10.1016\/j.autrev.2021.102987_bb0150","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1007\/s12185-009-0324-3","article-title":"MALT lymphoma of the thymus with Sj\u00f6gren\u2019s syndrome: biphasic changes in serological abnormalities over a 4-year period following thymectomy","volume":"89","author":"Sakamoto","year":"2009","journal-title":"Int J Hematol"},{"key":"10.1016\/j.autrev.2021.102987_bb0155","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1136\/annrheumdis-2019-216287","article-title":"Increased risk of multiple myeloma in primary Sj\u00f6gren\u2019s syndrome is limited to individuals with Ro\/SSA and La\/SSB autoantibodies","volume":"79","author":"Mofors","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2021.102987_bb0160","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1093\/rheumatology\/kei281","article-title":"Incidence of cancer in a cohort of patients with primary Sjogren\u2019s syndrome","volume":"45","author":"Lazarus","year":"2006","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2021.102987_bb0165","doi-asserted-by":"crossref","first-page":"157","DOI":"10.7861\/clinmedicine.14-2-157","article-title":"A retrospective study of long-term outcomes in 152 patients with primary Sj\u00f6gren\u2019s syndrome: 25-year experience","volume":"14","author":"Abrol","year":"2014","journal-title":"Clin Med (Lond)"},{"key":"10.1016\/j.autrev.2021.102987_bb0170","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1111\/1756-185X.13927","article-title":"Risk of malignancy in Korean patients with primary Sj\u00f6gren\u2019s syndrome","volume":"23","author":"Kang","year":"2020","journal-title":"Int J Rheum Dis"},{"key":"10.1016\/j.autrev.2021.102987_bb0175","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.rdc.2020.05.004","article-title":"Sj\u00f6gren syndrome and cancer","volume":"46","author":"Igoe","year":"2020","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1016\/j.autrev.2021.102987_bb0180","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.6737","article-title":"Increased risk of thyroid disease in patients with Sjogren\u2019s syndrome: a systematic review and meta-analysis","volume":"7","author":"Sun","year":"2019","journal-title":"PeerJ"},{"key":"10.1016\/j.autrev.2021.102987_bb0185","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jss.2007.09.020","article-title":"Is Hashimoto\u2019s thyroiditis a risk factor for papillary thyroid cancer?","volume":"150","author":"Repplinger","year":"2008","journal-title":"J Surg Res"},{"key":"10.1016\/j.autrev.2021.102987_bb0190","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.semcancer.2019.05.019","article-title":"Thyroid autoimmune disorders and cancer","volume":"64","author":"Ferrari","year":"2020","journal-title":"Semin Cancer Biol"},{"key":"10.1016\/j.autrev.2021.102987_bb0195","doi-asserted-by":"crossref","DOI":"10.1177\/2036361320972560","article-title":"Morphological and immunohistochemical approaches to the diagnosis of Hashimoto thyroiditis and mucosa associated lymphoid tissue lymphomas: an audit","volume":"12","author":"Rency","year":"2020","journal-title":"Rare Tumors"},{"key":"10.1016\/j.autrev.2021.102987_bb0200","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1159\/000502204","article-title":"Mucosa-associated lymphoid tissue lymphoma of the thyroid gland: a systematic review of the literature","volume":"9","author":"Karvounis","year":"2020","journal-title":"Eur Thyroid J"},{"key":"10.1016\/j.autrev.2021.102987_bb0205","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1038\/ncpuro0874","article-title":"Interstitial cystitis and systemic autoimmune diseases","volume":"4","author":"van de Merwe","year":"2007","journal-title":"Nat Clin Pract Urol"},{"key":"10.1016\/j.autrev.2021.102987_bb0210","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.jbspin.2014.12.007","article-title":"Sj\u00f6gren\u2019s syndrome complicated by interstitial cystitis: a case series and literature review","volume":"82","author":"Darrieutort-Laffite","year":"2015","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.autrev.2021.102987_bb0215","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1177\/0961203318811605","article-title":"Overactive bladder symptom bother and health-related quality of life in patients with systemic lupus erythematosus and primary Sj\u00f6gren syndrome","volume":"28","author":"Pereira","year":"2019","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2021.102987_bb0220","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0225455","article-title":"Overactive bladder and bladder pain syndrome\/interstitial cystitis in primary Sj\u00f6gren\u2019s syndrome patients: a nationwide population-based study","volume":"14","author":"Lee","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.autrev.2021.102987_bb0225","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.ygyno.2012.07.100","article-title":"Effect of autoimmune diseases on risk and survival in female cancers","volume":"127","author":"Hemminki","year":"2012","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.autrev.2021.102987_bb0230","article-title":"Risk of major autoimmune diseases in female breast cancer patients: a nationwide, population-based cohort study","volume":"14","author":"Chen","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.autrev.2021.102987_bb0235","article-title":"Sj\u00f6gren\u2019s syndrome is associated with reduced lifetime sex hormone exposure: a case-control study","author":"McCoy","year":"2019","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.autrev.2021.102987_bb0240","doi-asserted-by":"crossref","DOI":"10.1016\/j.semcancer.2020.10.008","article-title":"The impact of oral contraceptive use on breast cancer risk: state of the art and future perspectives in the era of 4P medicine","author":"Bonfiglio","year":"2021","journal-title":"Semin Cancer Biol"},{"key":"10.1016\/j.autrev.2021.102987_bb0245","doi-asserted-by":"crossref","DOI":"10.1158\/1055-9965.EPI-20-0358","article-title":"Breast cancer population attributable risk proportions associated with body mass index and breast density by race\/ethnicity and menopausal status","author":"Bissell","year":"2020","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.autrev.2021.102987_bb0250","first-page":"1","article-title":"The metabolic syndrome is a risk factor for breast cancer: a systematic review and meta-analysis","author":"Zhao","year":"2020","journal-title":"Obes Facts"},{"key":"10.1016\/j.autrev.2021.102987_bb0255","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1007\/s12026-016-8830-x","article-title":"Mastitis associated with Sj\u00f6gren\u2019s syndrome: a series of nine cases","volume":"65","author":"Goulabchand","year":"2017","journal-title":"Immunol Res"},{"key":"10.1016\/j.autrev.2021.102987_bb0260","article-title":"Autoimmunity and cancer","volume":"102882","author":"Masetti","year":"2021","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2021.102987_bb0265","doi-asserted-by":"crossref","first-page":"102650","DOI":"10.1016\/j.autrev.2020.102650","article-title":"Risk of cancer in multiple sclerosis (MS): a systematic review and meta-analysis","volume":"19","author":"Ghajarzadeh","year":"2020","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2021.102987_bb0270","doi-asserted-by":"crossref","first-page":"102687","DOI":"10.1016\/j.autrev.2020.102687","article-title":"Immune checkpoint inhibitors therapies in patients with cancer and preexisting autoimmune diseases: a meta-analysis of observational studies","volume":"19","author":"Xie","year":"2020","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2021.102987_bb0275","doi-asserted-by":"crossref","first-page":"102595","DOI":"10.1016\/j.autrev.2020.102595","article-title":"Rheumatic immune-related adverse events associated with cancer immunotherapy: a nationwide multi-center cohort","volume":"19","author":"Roberts","year":"2020","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2021.102987_bb0280","doi-asserted-by":"crossref","first-page":"102590","DOI":"10.1016\/j.autrev.2020.102590","article-title":"Immune checkpoint inhibitors-induced autoimmunity: the impact of gender","volume":"19","author":"Triggianese","year":"2020","journal-title":"Autoimmun Rev"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997221002676?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997221002676?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T21:23:54Z","timestamp":1761600234000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997221002676"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":56,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["S1568997221002676"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2021.102987","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cancer incidence in primary Sj\u00f6gren's syndrome: Data from the French hospitalization database","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2021.102987","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102987"}}